These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22633450)

  • 21. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer.
    Edler D; Hallström M; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H
    Clin Cancer Res; 2000 Apr; 6(4):1378-84. PubMed ID: 10778966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.
    Jakob C; Liersch T; Meyer W; Baretton GB; Schwabe W; Häusler P; Kulle B; Becker H; Aust DE
    Am J Surg Pathol; 2006 Sep; 30(9):1169-74. PubMed ID: 16931962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
    Formentini A; Henne-Bruns D; Kornmann M
    Hepatogastroenterology; 2012 Sep; 59(118):1859-64. PubMed ID: 22819905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer.
    Kim JW; Kim YB; Choi JJ; Koom WS; Kim H; Kim NK; Ahn JB; Lee I; Cho JH; Keum KC
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e577-84. PubMed ID: 22981710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.
    Dotor E; Cuatrecases M; Martínez-Iniesta M; Navarro M; Vilardell F; Guinó E; Pareja L; Figueras A; Molleví DG; Serrano T; de Oca J; Peinado MA; Moreno V; Germà JR; Capellá G; Villanueva A
    J Clin Oncol; 2006 Apr; 24(10):1603-11. PubMed ID: 16575011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891.
    Smeenk HG; van Eijck CH; Hop WC; Erdmann J; Tran KC; Debois M; van Cutsem E; van Dekken H; Klinkenbijl JH; Jeekel J
    Ann Surg; 2007 Nov; 246(5):734-40. PubMed ID: 17968163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of thymidylate synthase in relation to survival and chemosensitivity in gastric cancer patients.
    Tsujitani S; Konishi I; Suzuki K; Oka S; Gomyo Y; Matsumoto S; Hirooka Y; Kaibara N
    J Exp Clin Cancer Res; 2000 Jun; 19(2):189-95. PubMed ID: 10965817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant tegafur.
    Grau JJ; Domingo-Domenech J; Morente V; Pera M; Garcia-Valdecasas JC; Fuster J; Bombí A; Mellado B; Albanell J; Gascón P
    Oncology; 2004; 66(3):226-33. PubMed ID: 15218314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymidylate synthase expression in primary colorectal tumours is correlated with its expression in metastases.
    Bendardaf R; Elzagheid A; Lamlum H; Algars A; Korkeila E; Ristamäki R; Collan Y; Syrjänen K; Pyrhönen S
    Scand J Gastroenterol; 2007 Apr; 42(4):471-6. PubMed ID: 17454857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
    Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
    Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Kamoshida S; Matsuoka H; Ishikawa T; Maeda K; Shimomura R; Inada K; Tsutsumi Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):594-601. PubMed ID: 15591457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracil.
    Hosokawa A; Yamada Y; Shimada Y; Muro K; Hamaguchi T; Morita H; Araake M; Orita H; Shirao K
    Int J Clin Oncol; 2004 Oct; 9(5):388-92. PubMed ID: 15549590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Clin Transl Oncol; 2012 May; 14(5):391-5. PubMed ID: 22551547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymidylate synthase expression in normal colonic mucosa: a predictive marker of toxicity in colorectal cancer patients receiving 5-fluorouracil-based adjuvant chemotherapy.
    Santini D; Vincenzi B; Perrone G; Rabitti C; Borzomati D; Caricato M; La Cesa A; Grilli C; Verzì A; Coppola R; Tonini G
    Oncology; 2004; 67(2):135-42. PubMed ID: 15539918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymidylate synthase expression and prognosis of patients with gastrointestinal cancers receiving adjuvant chemotherapy: a review.
    Formentini A; Henne-Bruns D; Kornmann M
    Langenbecks Arch Surg; 2004 Oct; 389(5):405-13. PubMed ID: 15309542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy.
    Murata Y; Hamada T; Kishiwada M; Ohsawa I; Mizuno S; Usui M; Sakurai H; Tabata M; Ii N; Inoue H; Shiraishi T; Isaji S
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):413-25. PubMed ID: 21898089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer.
    Tsuji T; Hidaka S; Sawai T; Nakagoe T; Yano H; Haseba M; Komatsu H; Shindou H; Fukuoka H; Yoshinaga M; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Tagawa Y
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3700-4. PubMed ID: 14506161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.